Since we launched the Foundation in 2011 we have invested more than 1.5 million euros in research.
We partner with academia, industry and non-profit organizations to accelerate the development of new treatments for Dravet síndrome. Our projects range from diagnostics to drug discovery, preclinical and clinical research.
List of research partners and projects:
Completed
Ongoing
Brain imaging in Dravet síndrome | |
Intracellular trafficking of Nav1.1 mutant proteins | |
Endocannabinoid system in Dravet syndrome | |
Developmed of A1783V Scn1a (conditional knock-in) Dravet mouse model and distribution among the Dravet community*** | |
Spanish and European Dravet síndrome population estimates | |
Characterization of the European population with Dravet síndrome | |
Cannabidiol in Epilepsy European meeting | |
The Future of Refractory Epilepsy Syndromes, European meeting | |
Research on genetic-basis and genetic-modifiers | |
Screening of repurposing libraries on zebrafish Dravet model*,** | |
Development of cognition assays using zebrafish Dravet model*,** | |
Development of cognition clinical biomarkers |
* co-financed by the Swiss Dravet Syndrome Association
** co-financed by the German Dravet Syndrome Association
*** co-financed by the Dravet Syndrome European Federation